D.E. Shaw & Co’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$241K Buy
2022
Q1
$1.04M Buy
2021
Q4
$1.08M Buy
2021
Q3
$227K Sell
2021
Q2
$320K Sell
2021
Q1
$497K Sell
2020
Q4
$879K Buy
2020
Q3
$669K Buy
2020
Q2
$860K Buy
2020
Q1
$127K Buy
2019
Q3
Sell
2019
Q2
$345K Buy
2019
Q1
$152K Buy